‘Dream Team’ stands up to melanoma cancer

 December 14, 2011:

Joe Caspermeyer, Biodesign Institute via http://asunews.asu.edu/20111214_melanomadreamteam

ASU’s Deirdre Meldrum and Joshua LaBaer, of the Biodesign Institute, have been named to the new Melanoma Dream Team created by Stand Up to Cancer, the Melanoma Research Alliance and the American Association for Cancer Research (AACR). The collaborative Dream Team project, involving scientists from top research institutions across the country, is focused on developing targeted, personalized therapies for a subtype of skin cancer that is difficult to treat. The Translational Genomics Research Institute (TGen) and the Barbara Ann Karmanos Cancer Institute will lead the $6 million national and international study.Continue reading

Luceome Biotechnologies Receives $1.9 Million in Phase I and Phase II SBIR Funding to Advance its High Throughput Screening Platform

TUCSON, AZ – LUCEOME BIOTECHNOLOGIES a privately held biotechnology company focused on the discovery and development of its innovative proprietary assay platform today announced the award of $1.6 million in grant funding from The National Institutes of Health to further their research in high throughput screening using the KinaseSeeker™ technology. Earlier this year, Luceome was awarded a grant for $287K for research in the area of poly(ADP-ribose) detection.

Continue reading